ArticleRSC advances2019

A minimal structural variation can overcome tumour resistance of oxaliplatin: the case of 4,5-dehydrogenation of the cyclohexane ring.

Paride Papadia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.